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Abstract 
Purpose: To evaluate the antibacterial and cytotoxic activities of the secondary metabolites of 
Lobophytum sp. 
Methods: Maceration with methanol: chloroform (1:1) was applied to extract the coral material. 
Chromatographic and spectroscopic techniques were employed for fractionation, isolation and 
elucidation of pure compounds. Antibacterial activities were performed by well diffusion method against 
three Gram-positive and four Gram-negative bacteria. Brine shrimp lethality test was employed to 
predict toxicity, while antitumor activity were tested by 3-(4, 5-dimethylthiazol-2-yl)-2, 5-
diphenyltetrazolium bromide (MTT) method against Ehrlich carcinoma cells.  
Results: Four sesquiterpenes, one cembranoid type diterpenes and two steroids were isolated. 1 
exhibited significant antibacterial activity against four tested bacteria (P. aeruginosa, S. aureus, S. 
epidermis, and S. pneumonia) with MIC value of 15 μg/mL. Moreover, 1 showed high diameter zone of 
inhibition ranging from 16 - 18 mm against test bacteria. Compounds 4 and 5 displayed moderate 
antibacterial activity against all test bacteria with inhibition zone diameter (IZD) ranging from 11 – 15 
mm and MIC values of 30 μg/mL. 2, 3, 6 and 7 exhibited weak antibacterial activity (IZD, 7 - 11 mm; 
MIC ≥ 30 μg/mL). In addition, only diterpene compound (4) showed high toxicity against A. Salina and 
antitumor activity against Erhlich carcinoma cells with the LD50 of 25 and 50 μg/mL, respectively.  
Conclusion: This study reveals the strong antibacterial activity of sesquiterpene alismol (1) and the 
potential antibacterial and antitumor activity of cembranoid type diterpene, cembrene A (4).  
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Marine soft corals of the subclass Alcyonaria 
(Octocorallia) have fascinated a great attention in 
the light of the structural diversity and broad 
range of biological activities of their metabolites, 
such as sesquiterpenoids, diterpenoids, 
tetraterpenoids and steroids [1]. In a continuing 
efforts at studying marine metabolites, collected 
from Red Sea Saudi Arabia, with biological 
activity, we have previously isolated several 
bioactive secondary metabolites from 
Sarcophyton trocheliophorum and S. glaucum [2-
5] Recently, our interest in allcyonaria coral, led 
us to isolate several secondary metabolites from 
Lobophytum sp. Literature survey showed that  
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metabolites of Lobophytum sp exhibited various 
biological activities, such as antitumor [6-13], 
antibacterial [14], anti-inflammatory activities [14-
16] and antiviral [17]. Our investigation led to the 
isolation and characterization of four 
sesquiterpenes: alismol (1), nardol (2) aristol-9-
ene (3), alismoxide (5), one cembranoid type 
diterpene, cembrene A (4), and two steroid type 
compounds, Chalinasterol (6) and Nephalsterol 
C (7). To the best of our knowledge, this is the 
first report of the presence of sesquiterpenes 
from soft coral Lobophytum sp. Antibacterial and 
antitumor activities of all metabolites were also 
evaluated. This paper describes isolation, NMR 







The soft coral, Lobophytum sp., was collected in 
May. 2014, off the Saudi Arabia Red Sea Coast 
at Jeddah and identified by Dr. Mohsen El-
Sherbiny (Marine Biology Department, Faculty of 
Marine Sciences, King Abdulaziz University). 
Voucher sample (no. JAD 09063B) was 
deposited in the herbarium of the Marine Biology 
Department, Faculty of Marine Sciences, King 
Abdulaziz University, Jeddah, Saudi Arabia 
 
General experimental procedures 
 
Chromatographic material: Silica gel 60 for 
column chromatography (60–120 mesh LR), for 
thin-layer chromatography. TLC aluminum 
sheets 20 x 20 cm. Silica gel 60 F254 was used 
for preparative, Pre-coated TLC glass plates SIL 
G-25 UV254, 0.25 mm silica gel (E. Merck, 
Darmstadt, Germany). Nuclear Magnetic 
Resonance spectra were recorded for 1D- and 
2D-NMR: Bruker AVANCE III WM at 600 MHz 
and 13C-NMR at 150 MHz spectrometer. 
Chemical shifts are given d (ppm) relative to 
TMS as internal standard. Electron impact mass 
spectra were determined at 70 eV using a Kratos 
GCMS-25 instrument. All chemicals were 
purchased from Sigma Chemical Company (St. 
Louis, MO. USA). 
 
Bacterial isolates  
 
Seven bacteria were obtained from King Fahd 
General Hospital, Jeddah, Saudi Arabia; they 
were Staphylococcus aureus, Staphylococcus 
epidermidis, and Streptococcus pneumonia 
(Gram-positive bacteria), Pseudomonas 
aeruginosa, Escherichia coli, Klebsiela 
pneumoniae, and Acinetobacter spp (Gram-
negative bacteria), Brine shrimp Artemia salina, 
and Ehrlich carcinoma cells were from the culture 
collection of Microbiology Department, Faculty of 
Science, King Abdulaziz University, Jeddah, 
Saudi Arabia. 
 
Extraction and isolation 
 
Coral material was washed with water and dried 
in the shade at room temperature. The dried 
material (90 g) was exhaustively extracted by 
maceration method with equal volumes of 




Figure 1: Chemical structures of 1 - 9 
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The residue (20 g) was chromatographed on NP 
(Merck, 60G) column chromatography employing 
n-hexane/methylene chloride, followed by ethyl 
acetate/methanol mixtures with increasing 
polarity. Fractions of ~100 mL were collected. 
TLC was carried out by employing silica gel 
chromatoplates, appropriate solvent system, and 
50 %-sulfuric acid in methanol as spraying 
reagent. Fractions containing a single compound 
were combined and further purified by 
preparative TLC of glass supported silica gel 
plates (20 x 20 cm) of 250 μm thickness. 
 
The fraction 1 eluted with n-hexane - 
dichloromethane (9:1, 37.00 mg) was purified by 
preparative TLC using solvent system n-hexane: 
ethyl acetate (9:1) to give two bands. The first 
band with Rf = 0.96 (brown color with sulfuric 
acid–methanol) was taken to give compound 3 
as crystalline (5.0 mg).  The second band with Rf 
= 0.36 (black color with sulfuric acid–methanol) 
was taken to give compound 4 as colorless oil 
(4.8 mg). The fraction 2 eluted with n-hexane - 
dichloromethane (7:3, 35.00 mg) was purified by 
preparative TLC using the solvent system n-
hexane:ethyl acetate (8:2) to give two bands. 
The first band with Rf = 0.48 (broad purple color 
after spraying with sulfuric acid–methanol) was 
taken to give crystalline of compound 1 (6.5 mg). 
The second band with Rf = 0.30 (purple color 
with sulfuric acid–methanol) was taken to give 
colorless oil of compound 2 (4.6 mg). The 
fraction 3 eluted with n-hexane - 
dichloromethane (5:5, 40.00 mg) was purified by 
preparative TLC using solvent system n-hexane: 
ethyl acetate (7:3) to give one band with Rf = 
0.72 (brown color with sulfuric acid–methanol) 
was taken to give compound 6 as crystalline (5.0 
mg). The fraction 4 eluted with 
dichloromethane:ethyl acetate (9:1, 42.00 mg) 
was purified by preparative TLC using the 
solvent system n-hexane : ethyl acetate (6:4) to 
give one band with Rf = 0.38 (broad purple color 
after spraying with sulfuric acid–methanol) was 
taken to give crystalline of compound 5 (8.0 mg). 
The fraction 5 eluted with dichloromethane:ethyl 
acetate (8:2, 41.00 mg) was purified by 
preparative TLC using the solvent system n-
hexane:ethyl acetate (5:5) to give one band with 
Rf = 0.62 (brown color after spraying with sulfuric 
acid–methanol) was taken to give powder of 
compound 7 (4.2 mg).  
 
Antibacterial activity assay 
 
The growth inhibition of the isolated compounds 
against several pathogenic bacteria was carried 
out using agar well diffusion method as 
described by Holder and Boyce (1994) [18]. 0.1 
mL of suspended bacterium in sterile medium 
(1.5 x 108 CFU/mL) was spread on Mueller–
Hinton agar. 50 μl of each sample (10 μg/mL) 
were poured to the wells (6-mm diameter). All 
plates were left for 1 h at 48 oC and then 
incubated for 24 h at 37 oC. Inhibition zone 
diameters formed around the well were 
measured and mean diameter of three replica 
was calculated. DMSO was used as a negative 
control and ampicillin as a positive control. 
Minimum inhibitory concentrations (MICs) were 
determined by modified method described by 
Chand et al [19] and Aly and Gumgumji [20]. 175 
μL of an exponentially growing culture (x106–107 
CFU/mL) was delivered into each well of 
microtiter plate along with 20 μL solution of each 
concentration of the isolated compounds. The 
appropriate solvent was used as control. After 
incubation for 40 min., 5 μL of a solution of 
Fluorescein diacetate (FDA) 0.2 % (w/v) in 
acetone was added into microtiter plate, then the 
incubation was continued for 90 min. The green 
color produced from the hydrolysis of FDA was 
measured at 490 nm (MR7000 automatic ELISA 
tray reader) along with the blanked wells and 
control wells containing microbial cultures. 
 
Toxicity activity assay 
 
The cytotoxicity of the isolated compounds can 
be measured by using brine shrimp lethality test 
[21]. Isolated compounds were dissolved in 
DMSO at varying concentrations and then 
incubated with the brine shrimp larvae in sea 
water. Brine shrimp larvae as positive control and 
DMSO as negative control were also incubated. 
The average number of larvae that survived in 
each vial was determined after 24 h. The mean 
of mortality percentage was plotted against the 
logarithm of concentrations. The concentration 
that killed fifty percent of the larvae (LC50) was 
determined from the graph. 
 
Antitumor activity assay 
 
Ehrlich carcinoma cell lines was used to 
determine the antitumor activity of the isolated 
compounds. The cells were grown in Roswell 
Park Memorial Institute (RPMI) 1640 medium 
(Sigma, USA) with 10 % fetal calf serum (Gibco, 
USA) at 37 oC under a humidified atmosphere 
(95 % air and 5 % CO2) for 48 h. Cells were 
treated with different concentration of the isolated 
compounds (200–1,000 μl/mL) for 24 h, 
centrifuged for 2 min at 1,500 g and counted 
under hemacytometer after removing the 
supernatant using trypan blue (Sigma, USA) in 
normal saline (1:1 v/v). The percentage of cell 
viability was assessed to determine the 50 % 
lethal dose by which 50 % of cells are killed 
(LD50).  
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All experiments were performed in triplicate. Data 
are presented as mean ± standard deviation 
(SD). Unpaired student t-test was carried out to 
detect any significant differences between the 
results of control and the treated sampels using 
GraphPad InStat (ISI Software). Differences 






Identification of secondary metabolites was 
analyzed based on MS and 1D/2D NMR data 
and comparison with the literature. The chemical 
structure of isolated compounds can be seen in 
the Fig. 1. 
 
Alismol (1): Colorless oil; HRESIMS: 
m/z=220.3505 (Calc. for C15H24O, 220.1820); 1H 
NMR (600 MHz, CDCl3): δH 5.55 (1H, br s, H-6), 
4.76 (1H, s, Ha-15), 4.70 (1H, s, Hb-15), 2.28 
(1H, dd, J= 14.4, 7.4 Hz, H-5), 2.50 (dd, J= 21.6, 
10.2 Hz, H1-1), 2.06 (dd, J=38.4, 10.2 Hz, H2-1), 
2.30 (1H, d, J= 7.4 Hz, H-1), 2.24 (1H, m, H-11), 
2.20 (1H, m, Ha-8), 2.10 (1H, m, Hb-8), 1.90 (1H, 
m, H-2), 1.74 (2H, m, H-3), 1.72 (1H, m, H-2’), 
1.25 (3H, s, H-14), 1.01 (3H, d, J = 6.6 Hz, H-
12), 0.98 (3H, d, J = 6.6 Hz, H-13); 13C NMR 
(200 MHz, CDCl3): δC 153.93 (C-10), 149.78 (C-
7), 121.30 (C-6), 106.51 (C-15), 80.69 (C-4), 
55.01 (C-1), 47.27 (C-5), 40.25 (C-3), 37.44 (C-
11), 37.08 (C-9), 30.00 (C-8), 24.76 (C-2), 24.09 
(C-14), 21.48 (C-13), 21.30 (C-12). 
 
Nardol (2): Colorless Oil; HRESIMS: 
m/z=222.3663 (Calc. for C15H26O, 222.1984); 1H 
NMR (600 MHz, CDCl3): δH 4.73 (1H, s, H-15’), 
4.71 (1H, s, H-15), 2.89 (1H, d, H-1), 2.40 (1H, 
m, H-9), 2.30 (1H, m, H-7), 2.16 (1H, m, H-8), 
2.14 (1H, m, H-9’), 1.94 (1H, m, H-6), 1,84 (1H, 
m, H-3), 1.72 (1H, m, H-6’), 1.71 (1H, m, H-5), 
1.62 (1H, m, H-3’), 1.58 (1H, m, H-11), 1.52  (1H, 
m, H-8’),  1.44 (3H, s, H-14), 1.30 (2H, m, H-2), 
1.01 (3H, d, J = 6.6 Hz, H-12), 0.96 (3H, d, J = 
6.6 Hz, H-13); 13C NMR (200 MHz, CDCl3): δC 
151.63 (C-10), 107.28 (C-15), 80.31 (C-4), 62.18 
(C-1), 57.57 (C-5), 47.91 (C-7), 41.50 (C-3), 
34.58 (C-11), 34.06 (C-9), 29.15 (C-8), 26.27 (C-
6), 24.95 (C-14), 22.71 (C-2), 18.72 (C-13), 
17.74 (C-12). 
 
Aristol-9-ene (3): Colorless oil; HRESIMS: m/z= 
204.3511 (Calc. for C15H24, 204.1878); 1H NMR 
(600 MHz, CDCl3): δH 5.10 (1H, ddd, 2.4,2.4,4.2 
Hz, H-9), 2.16 (1H, m, H-1), 1.98 (1H, m, H-1),  
2.08 (1H, dd, 2.4, 4.2, Ha-8), 2,04 (1H, dd, 2.4, 
4.2, Hb-8), 1.69 (1H, dd, 1.2, 2.4, H-4), 1.62 (H, 
m, Ha-3), 1.42 (1H, m, Ha-2), 1.36 (1H, m, Hb-3), 
1.3 (1H, m, Hb-2), 1.18 (3H, s, H-13), 1.12 (3H, 
s, H-12), 1.05 (3H, s, H-15), 0.98 (3H, d, J=4.8 
Hz, H-14), 0.75 (1H, dd, J= 6, 8.5 Hz, H-7), 0.60 
(1H, d, J= 8.5 Hz, H-6); 13C nmr (200 MHz, 
CDCl3): δC 141.30 (C-10), 118.5 (C-9), 37.86 (C-
4), 36.82 (C-5), 33.04 (C-1), 32.09 (C-6), 31.32 
(C-2), 28.44 (C-7), 27.21 (C-3) 21.77 (C-8), 
21.29 (C-13), 19.29 (C-14), 17.9 (C-11), 15.91 
(C-12), 15.65 (C-15).  
 
Cembrene A (4): Colorless oil, HRESIMS: m/z= 
272.4681 (Calc.for C20H32, 272.2504); 1H NMR 
(600 MHz, CDCl3): δH 5.31 (1H, dd, J= 6.8, 15.3 
Hz, H-7), 5.25 (1H, dt, J=1.7, 6.8, 8.5 Hz, H-3), 
5.08 (1H, dt, J= 6.0, 12.0, H-11), 4.82 (2H, d, 
J=1.0, H-16), 2.26, (1H, m, Ha-6), 2.21 (1H, 
dddd, J=3.4, 4.25, 10.2, 13.6 Hz, H-1), 2.17 (1H, 
m, Ha-2), 2.15 (2H, m, H-10), 2.15 (1H, m, Ha-5), 
2.13 (1H, m, Hb-6), 2.12 (1H, m, Ha-13), 2.09 
(2H, m, H-9), 2.02 (1H, m, Hb-2), 1.96 (1H, m, 
Hb-5), 1.93 (1H, m, Hb-13), 1.79 (dq, J= 10.2; 
13.6 Hz, Ha-14), 1.41 (m, Hb-14), 1.63 (3H, s, H-
17), 1.60 (3H, s, H-18), 1.55 (3H, s, H-19), 1.54 
(3H, s, H-20);  13C NMR (150 MHz, CDCl3); δC 
148.87 (C-15), 134.55 (C-8), 133.48 (C-4), 
133.10 (C-12), 126.08 (C-11), 124.19 (C-7), 
121.91 (C-3), 110.44 (C-16), 46.17 (C-1), 39.49 
(C-9), 39.01 (C-5), 33.99 (C-13), 32.64 (C-2), 
28.19 (C-14), 24.98 (C-6), 23.85 (C-10), 18.99 
(C-17), 17.97 (C-18), 15.5 (C-19), 15.28 (C-20). 
 
Alismoxide (5): Colorless oil, HRESIMS: m/z= 
238.3657 (Calc. for C15H26O2, 238.1930), 1H 
NMR (600 MHz, CDCl3): δH 5.50 (1H, dd, J = 2.0; 
1.2 Hz, H-6), 2.24 (1H, sept, H-11), 2.22 (1H, m, 
Ha-8), 2.18 (1H, m, H-5), 1.95 (1H, dd, 10.4; 1.2 
Hz, Hb-8), 1.89 (1H, m, H-1), 1.80 (1H, m, Ha-2), 
1.80 (1H, m, Ha-9), 1.70 (1H, m, Ha-3), 1.68 (1H, 
m, Hb-2), 1.62 (1H, m, Hb-3), 1.47 (1H, m, Hb-9),  
1.27 (3H, s, H-14), 1.21 (3H, s, H-15), 0.99 (3H, 
d, J = 6.8 Hz, H-12), 0.98 (3H, J=6.8 Hz, H-13); 
13C NMR (150 MHz, CDCl3): δC 149.69 (C-7), 
121.33 (C-6), 80.25 (C-4), 75.25 (C-10), 50.77 
(C-1), 50.38 (C-5), 42.67 (C-9), 40.52 (C-3), 
37.33 (C-11), 25.12 (C-8), 21.44 (C-14), 21.55 
(C-2), 22.61 (C-15), 21.20 (C-13), 21.42 (C-12). 
 
Chalinasterol (6): Amorphous powder, 
HRESIMS: m/z= 398.6642 (Calc. for C28H46O, 
398.3540), 1H NMR (600 MHz, CDCl3); δH 5.38 
(1H, s, H-6), 4.71 (1H, s, Ha-28), 4.65 (1H, s, Hb-
28), 3.6 (1H, m, H-3), 1.03 (3H, d, J = 6.8 Hz, H-
27), 1.02 (3H, d, J=6.8 Hz, H-26’), 1.01 (3H, s, H-
19), 0.98 (3H, d, J=6.8 Hz, H-26), 0.94 (3H, d, J= 
6.8, H-21), 0.68 (3H, s, H-18). 13C NMR (150 
MHz, CDCl3): δC 156.98 (C-24), 140.79 (C-5), 
121.73 (C-6), 105.91 (C-28), 71.83 (C-3), 56.77 
(C-14), 55.99 (C-17), 50.13 (C-9), 42.37 (C-13), 
42.31 (C-4), 39.79 (C-12), 37.48 (C-1), 36.51 (C-
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10), 35.7 (C-20), 34.69 (C-23), 33.81 (C-25), 
38.58 (C-8), 32.0 (C-7), 31.68 (C-2), 30.98 (C-
22), 28.23 (C-16), 24.3 (C-15), 22.01 (C-27), 
21.88 (C-26), 21.10 (C-11), 19.42 (C-19), 18.72 
(C-21), 11.88 (C-18). 
 
Nephalsterol C (7): Amorphous powder, 
HRESIMS: m/z= 472.6997 (Calc. for C30H48O4, 
472.3550), 1H NMR (600 MHz, CDCl3): δH 5.58 
(1H, t, J = 2 Hz, H-6), 4.90 (1H, dd, J = 2.5, 6 Hz, 
H-7), 4.71 (1H, d, J = 0.85 Hz, Ha-28), 4.65 (1H, 
d, J = 0.85 Hz, Hb-28), 3.80 (1H, d, J = 11.9 Hz, 
H-19), 3.65 (1H, d, J = 11.9 Hz, H-19’), 3.60 (1H, 
tt, J = 10.2 5.1 Hz, H-3), 2.38 (1H, dddd, J = 1.7, 
2.5, 4.25, 5.95 Hz, H-4), 2.20 (1H, tt, 6.8, 12.75, 
H-4’), 2.02 (3H, s, OAc), 1.02 (3H, d, J = 5.1 Hz, 
H-26), 1.01 (3H, d, J = 5.1 Hz, H-27), 0.94 (3H, 
d, J = 5.9 Hz, H-21), 0.74 (3H, s, H-18). 13C NMR 
(150 MHz, CDCl3): δC 171.38 (MeCOO-), 156.81 
(C-24), 140.02 (C-5), 126.78 (C-6), 106.02 (C-
28), 75.11 (C-7), 70.92 (C-3), 62.9 (C-19), 56.33 
(C-14), 55.27 (C-17), 48.53 (C-9), 42.6 (C-13), 
41.63 (C-4), 41.45 (C-10), 39.74 (C-12), 35.65 
(C-8), 37.84 (C-20), 34.65 (C-22), 33.78 (C-25), 
33.20 (C-1), 31.80 (C-2), 30.95 (C-23), 28.39 (C-
16), 24.98 (C-15), 21.73 (C-26), 21.86 (C-27), 





Antibacterial activity assay were performed 
against several bacteria. The result of diameter 
of zone of inhibitons (mm) of isolated compounds 
were presented in Table 1. There were 
significant differences (p < 0.05) among 
antibacterial activities of all isolated compounds. 
Compound 1 has significant antibacterial activity 
(p < 0.05) against both gram-positive bacteria (S. 
aureus, S. S. epidermis and S. pneumonia) and 
gram-negative bacteria (P. aeruginosa) with the 
MIC value of 15 μg/mL (Table 2). Moreover, 
compound 1 showed the larger diameter of 
inhibition zone ranging from 16-18 mm against 
those four bacteria. The diameter of inhibition 
zone against S. epidermis was recorded to be 
largest (18 ± 2.0 mm). Meanwhile, compound 4 
and 5 exhibited moderate antibacterial activity 
with the diameter of inhibiton zone ranging from 
11 – 15 mm and MIC value of 30 μg/mL.  
Compound 2, 3, 6 and 7 showed weak 
antibacterial activity with diameter of inhibition 
zone ranging from 7 – 10 mm and MIC value ≥ 
30 μg/mL. 
 
Toxicity and antitumor activity  
 
The result of toxicity and antitumor activity test 
can be seen in Table 3. All compounds did not 
show appreciable toxicity and antitumor 
properties against Artemia salina and Erhlich 
carcinoma cells, except for cembrene A 
(compound 4). It exhibited significant toxicity and 
antitumor activity (p < 0.05) with the LD50 values 




Compound 1 was isolated as colorless oil. 
HRESIMS at m/z of 220.3505 and 13C NMR 
suggesting a molecular formula of C15H24O with 4 
degrees of unsaturation. The obtained 
spestroscopic data (cf. exp.) was found to be 
identical with the structural data of alismol, a 
guaiane sesquiterpene isolated previously from 
the rhizome of Alisma plantago-aquatu L var 
orlentale Samuelsson (Altsmataceae) [22,23]. 
 
 
Table 1: Antibacterial activity of compounds 1-7 
 
Test bacteria 
Mean diameter of the inhibition zone (mm) ± SD* 
1 2 3 4 5 6 7 Ampicillin+ 
Acinetobacter 
spp 14±0.23 7±0.0 10±0.22 14±0.24 14±1.3 9±0.0 7±0.3 14±0.14 
Escherichia coli 12±0.12 7±0.0 10±0.22 13±0.34 15±2.0 7±0.0 7±1.0 16±0.42 
Klebsiella 
Pneumonia 14±1.24 9±0.14 10±0.14 13±0.14 12±1.3 10±0.0 7±1.0 16±0.33 
Pseudomonas  
aeruginosa 17±0.4 7±0.00 7±0.00 13±0.22 11±1.1 7±0.0 7±0.0 18±0.24 
Staphylococcus 
aureus 16±0.22 7±0.0 7±0.00 11±0.33 13±2.0 7±0.0 9±1.0 26±0.22 
Staphylococcus 
epidermidis 18±2.0 7±0.0 7±0.8 11±0.22 14±2.6 10±1.3 7±1.0 34±4.20 
Streptococcus 
pneumonia 16±0.8 7±0.0 10±0.2 11±0.19 15±3.1 10±1.3 7±1.4 34±1.40 
+Ampicillin used as control positive, *: Significant difference was recorded between all the tested value and 
ampicillin at p < 0.05 
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Table 2: MIC of compounds 1-7 
 
Test bacteria MIC (μg/mL) 1 2 3 4 5 6 7 Ampicillin+ 
Acinetobacter 
spp 30* ≥30 30* 30* 30* ≥30 30* - 
Escherichia coli 30* ≥30 30* 30* 30* ≥30 30* 2±0.2 
Klebsiella 
pneumonia 30* ≥30 30* 30* 30* ≥30 30* 2±0.2 
Pseudomonas  
aeruginosa 15* ≥30 ≥30 30* 30* ≥30 30* 3±0.2 
Staphylococcus 
aureus 15* ≥30 ≥30 30* 30* ≥30 30* 5±0.4 
Staphylococcus 
epidermidis 15* ≥30 ≥30 30* 30* 30* 30* 5±0.2 
Streptococcus 
pneumonia 15* ≥30 30* 30* 30* 30* 30* - 
+Ampicillin was used as control positive, *: significant difference at p < 0.05 
 
Table 3: Toxicity and antitumor activity of compounds 1-7 
 
Test LD50 (μg/mL) 1 2 3 4 5 6 7 Controla 
Toxicity against 




ND ND ND 50* 100 ≥250 ≥250 30 
aQuinidine sulfate used as positive control for toxicity assay and elspar (trade name for asparaginase) for 
antitumor assay, ND = not detected; *significant difference at p < 0.05 
 
Compound 2 was isolated as colorless oil. A 
search of chemical database using science finder 
found that the spectroscopic data of 2 was in 
accordance with the chemical structure of 
nardol, isolated previously from the rhizome of 
Nardostachys jatamansi [24]. This is the first 
report of 13C-NMR from this compound. 
 
Compound 3 was isolated as colorless oil. The 
resulted spectroscopic data (cf. exp.) gave 
conclusion that the compound similar to aristol-
(9)-ene, previously isolated from a soft coral 
Lemnalia humesi [25]. 
 
Compound 4 was isolated as colorless oil. 4 was 
found to be Cembrene A, a cembranoid 
previously isolated from the paracloacal glands 
of the Chinese Alligator (Alligator sinensis) [26].  
 
Compound 5 was isolated as colorless oil. The 
spectroscopic data of 5 (Cf. exp.) was found to 
be stereochemically similar with the structure of 
alismoxide, a guaianediol with stereostructure 
1S*, 4S*, 5S*, 10R*-4, 10-guaianediol, isolated 
previously from the rhizome of Alisma plantago-
aquatu and soft coral Sinularia sp. [22,27].  
 
Compound 6 was isolated as amorphous 
powder. The obtained spectroscopic data (cf. 
exp.) of 6 was found to be stereochemically 
similar with the structure of chalinasterol, a 
steroid isolated previously from a soft coral of 
Sinularia gibberosa and Lytophyton arboretum 
[28,29]. 
 
Compound 7 was isolated as amorphous 
powder. A constructed structure based on the 
analysis of the spectral data (cf. exp.) was 
searched by science finder and found to be 
similar in structure with Nephalsterol C, a steroid 
isolated previously from a soft coral Lytophyton 
arboreum [29]. 
 
Biological activity assays confirmed that 
isoprenoids type compounds from Lobophytum 
sp. possessing antibacterial and antitumor 
activity. Compound 1 (alismol) has strong 
antibacterial activity against both gram positive 
(S. aureus, S. epidermis, and S. pneumonia) and 
negative bacteria (P. aeruginosa). Nevertheless, 
the antitumor activity was not detected. 
Compound 4 (cembrene A) showed moderate 
activity against all tested bacteria. Moreover, it 
also possesed high toxicity (25 μg/mL) against A. 
salina and appreciable antitumor activity (50 




Four sesquiterpenes, one cembranoid type 
diterpene and two steroids have been isolated 
and identified from the Red Sea soft coral 
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Lobophyton sp. Compound 1 (alismol) has 
significant antibacterial activity against gram-
positive (S. aureus, S. epidermis, and S. 
pneumonia) and gram-negative bacteria (P. 
aeruginosa). Compound 4 (cembrene A) also 
exhibited moderate antibacterial activity against 
all tested bacteria and appreciable antitumor 
properties against Erhlich carcinoma cells. 
Compounds 1 and 4 display potentials for 
treating pathogenic bacteria associated with 
many diseases and/or tumor and therefore, 
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